A novel GABAB receptor positive allosteric modulator, ASP8062, exerts analgesic effects in a rat model of fibromyalgia

The rat brain in stereotaxic coordinates

Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,959 · see citing works

The Rat Brain in Stereotaxic Coordinates

Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585 · see citing works

Two-Process Model of Sleep Regulation

Binder, M. D., Hirokawa, N., & Windhorst, U. (2008) · Springer eBooks · doi:10.1007/978-3-540-29678-2_6166 · Cited by 3,895 · see citing works

Musculosketal Symptoms and Non-REM Sleep Disturbance in Patients with “Fibrositis Syndrome” and Healthy Subjects

Moldofsky, H., Scarisbrick, P., England, R. W., & SMYTHE, H. A. (1975) · Psychosomatic Medicine · doi:10.1097/00006842-197507000-00008 · Cited by 851 · see citing works

International Union of Pharmacology. XXXIII. Mammalian γ-Aminobutyric AcidB Receptors: Structure and Function

Bowery, N. G., Bettler, B., Froestl, W., Gallagher, J. P., Marshall, F. H., Raiteri, M., Bonner, T. I., & Enna, S. J. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.247 · Cited by 601 · see citing works

Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis

Russell, I. J., Værøy, H., Javors, M. A., & Nyberg, F. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350509 · Cited by 546 · see citing works

Role of central dopamine in pain and analgesia

Wood, P. B. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.5.781 · Cited by 373 · see citing works

Genetic and Pharmacological Evidence of a Role for GABAB Receptors in the Modulation of Anxiety- and Antidepressant-Like Behavior

Mombereau, C., Kaupmann, K., Froestl, W., Sansig, G., van der Putten, H., & Cryan, J. F. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300413 · Cited by 348 · see citing works

Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: A randomized, double‐blind, placebo‐controlled, multicenter clinical trial

Russell, I. J., Perkins, A. T., Michalek, J. E., & Oxybate SXB‐26 Fibromyalgia Syndrome Study Group (2008) · Arthritis & Rheumatism · doi:10.1002/art.24142 · Cited by 302 · see citing works

Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: A putative animal model of fibromyalgia

Nagakura, Y., Oe, T., Aoki, T., & Matsuoka, N. (2009) · Pain · doi:10.1016/j.pain.2009.05.024 · Cited by 261 · see citing works

Clinical Course of γ-Hydroxybutyrate Overdose

Chin, R. L., Sporer, K. A., Cullison‡, B., et al. (1998) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(98)70230-6 · Cited by 247 · see citing works

A Benefit-Risk Assessment of Baclofen in Severe Spinal Spasticity

Dario, A., & Tomei, G. (2004) · Drug Safety · doi:10.2165/00002018-200427110-00004 · Cited by 224 · see citing works

Reduced insular γ‐aminobutyric acid in fibromyalgia

Foerster, B. R., Petrou, M., Edden, R. A. E., Sundgren, P. C., Schmidt‐Wilcke, T., Lowe, S. E., Harte, S. E., Clauw, D. J., & Harris, R. E. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33339 · Cited by 212 · see citing works

The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia.

Scharf, M. B., Baumann, M. M., & Berkowitz, D. V. (2003) · PubMed · Cited by 201 · see citing works

Intramuscular injection of tumor necrosis factor-alpha induces muscle hyperalgesia in rats☆

Schäfers, M., Sorkin, L. S., & Sommer, C. (2003) · Pain · doi:10.1016/s0304-3959(03)00115-5 · Cited by 165 · see citing works

Cyclic alternating pattern: a new marker of sleep alteration in patients with fibromyalgia?

Rizzi, M., Sarzi‐Puttini, P., Atzeni, F., CAPSONI, F., Andreoli, A., Pecis, M., Colombo, S., Carrabba, M., & Sergi, M. (2004) · PubMed · Cited by 135 · see citing works

Animal models of fibromyalgia

DeSantana, J. M., Cruz, K. M. L., & Sluka, K. A. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4402 · Cited by 115 · see citing works

Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: Results from a 14-week, randomized, double-blind, placebo-controlled study

Russell, J. I., Holman, A. J., Swick, T. J., Alvarez-Horine, S., Wang, G., & Guinta, D. (2011) · Pain · doi:10.1016/j.pain.2010.12.022 · Cited by 103 · see citing works

Pathophysiologic mechanisms of fibromyalgia and its related disorders.

Bradley, L. A. (2008) · PubMed · Cited by 96 · see citing works

Chapter 13 Descending inhibitory systems

Pertovaara, A., & Almeida, A. (2006) · Handbook of clinical neurology · doi:10.1016/s0072-9752(06)80017-5 · Cited by 92 · see citing works

A single intrathecal injection of GABA permanently reverses neuropathic pain after nerve injury

Eaton, M. J., Martínez, M. Á. G., & Karmally, S. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01564-4 · Cited by 89 · see citing works

Sodium Oxybate

Robinson, D. M., & Keating, G. M. (2007) · CNS Drugs · doi:10.2165/00023210-200721040-00007 · Cited by 89 · see citing works

Allosteric Modulation of G Protein-Coupled Receptors

May, L. T., Avlani, V. A., Sexton, P. M., & Christopoulos, A. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384303 · Cited by 85 · see citing works

Allosteric Modulators of GABAB Receptors: Mechanism of Action and Therapeutic Perspective

Pin, J., & Prézeau, L. (2007) · Current Neuropharmacology · doi:10.2174/157015907781695919 · Cited by 84 · see citing works

Effect of baclofen on sleep‐related periodic leg movements

Guilleminault, C., & Flagg, W. (1984) · Annals of Neurology · doi:10.1002/ana.410150304 · Cited by 79 · see citing works

Sodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trial

Spaeth, M., Bennett, R. M., Benson, B. A., Wang, Y. G., Lai, C., & Choy, E. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200418 · Cited by 69 · see citing works

GABAB receptors in the median raphe nucleus: distribution and role in the serotonergic control of hippocampal activity

Varga, V., Attila Gabor, S. I. K., Freund, T. F., & Kocsis, B. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00448-1 · Cited by 68 · see citing works

GABAB receptors and pain

Malcangio, M. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.05.012 · Cited by 68 · see citing works

Clinical Potential of GABABReceptor Modulators

Ong, J. A., & Kerr, D. I. B. (2005) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2005.tb00049.x · Cited by 59 · see citing works

Spontaneous REM Sleep Is Modulated By the Activation of the Pedunculopontine Tegmental GABAB Receptors in the Freely Moving Rat

Ulloor, J., Mavanji, V., Saha, S. G., Siwek, D. F., & Datta, S. (2004) · Journal of Neurophysiology · doi:10.1152/jn.01104.2003 · Cited by 52 · see citing works

Management of Fibromyalgia Syndrome: Review of Evidence

Okifuji, A., & Hare, B. D. (2013) · Pain and Therapy · doi:10.1007/s40122-013-0016-9 · Cited by 49 · see citing works

Allosteric modulation of Class C GPCRs: a novel approach for the treatment of CNS disorders

Engers, D. W., & Lindsley, C. W. (2013) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2012.10.007 · Cited by 45 · see citing works

Analgesic effects of novel lysophosphatidic acid receptor 5 antagonist AS2717638 in rodents

Murai, N., Hiyama, H., Kiso, T., et al. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.08.032 · Cited by 45 · see citing works

Spontaneous and evoked pain-associated behaviors in a rat model of neuropathic pain respond differently to drugs with different mechanisms of action

Murai, N., Sekizawa, T., Gotoh, T., et al. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.11.008 · Cited by 39 · see citing works

Effects of Repeated Administration of Baclofen to Rats on GABAB Receptor Binding Sites and Subunit Expression in the Brain

Lehmann, A., Mattsson, J. P., Edlund, A., et al. (2003) · Neurochemical Research · doi:10.1023/a:1022353923578 · Cited by 37 · see citing works

The drug candidate, ADX71441, is a novel, potent and selective positive allosteric modulator of the GABAB receptor with a potential for treatment of anxiety, pain and spasticity

Kalinichev, M., Girard, F., Haddouk, H., Rouillier, M., Riguet, E., Royer-Urios, I., Mutel, V., Lütjens, R., & Poli, S. M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.11.016 · Cited by 29 · see citing works

A Review of Sodium Oxybate and Baclofen in the Treatment of Sleep Disorders

Brown, M. A., & Guilleminault, C. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796197098 · Cited by 26 · see citing works

Endogenous pain modulation : descending inhibitory systems

Pertovaara, A., & Almeida, A. (2006) · Cited by 16 · see citing works

Fibromyalgia: Mechanisms, Current Treatment and Animal Models

Brederson, J., Jarvis, M. F., Honoré, P., et al. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111798357258 · Cited by 16 · see citing works

Relationship between serotonin transporter occupancies and analgesic effects of AS1069562, the (+)-isomer of indeloxazine, and duloxetine in reserpine-induced myalgia rats

Murai, N., Fushiki, H., Honda, S., Murakami, Y., Iwashita, A., Irie, M., Tamura, S., Nagakura, Y., & Aoki, T. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2014.12.065 · Cited by 14 · see citing works

Analgesic effect of ADX71441, a positive allosteric modulator (PAM) of GABAB receptor in a rat model of bladder pain

Kannampalli, P., Poli, S.-M., Boléa, C., & Sengupta, J. N. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.08.023 · Cited by 14 · see citing works

ADX71943 and ADX71441, novel positive allosteric modulators of the GABA B receptor with distinct central/peripheral profiles, show efficacy in the monosodium iodoacetate model of chronic osteoarthritis pain in the rat

Kalinichev, M., Donovan-Rodríguez, T., Girard, F., et al. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.11.056 · Cited by 13 · see citing works

Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder

Burnette, E. M., Nieto, S. J., Grodin, E. N., Meredith, L. R., Hurley, B., Miotto, K., Gillis, A. J., & Ray, L. A. (2022) · Drugs · doi:10.1007/s40265-021-01670-3 · Cited by 169 · see citing works

Animal models of fibromyalgia: What is the best choice?

Brum, E. S., Becker, G., Fialho, M. F. P., & Oliveira, S. M. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107959 · Cited by 71 · see citing works

A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder

Celik, M., Gold, M. S., & Fuehrlein, B. (2024) · Brain Sciences · doi:10.3390/brainsci14030294 · Cited by 25 · see citing works

Single- and Multiple-Dose Safety, Tolerability, and Pharmacokinetic Profiles of ASP8062: Results From 2 Phase 1 Studies

Walzer, M., Marek, G. J., Wu, R., Nagata, M., & Han, D. (2020) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.766 · Cited by 19 · see citing works

Discovery of a Negative Allosteric Modulator of GABAB Receptors

Chen, L., Sun, B., Zhang, Y., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500162z · Cited by 29 · see citing works

Mode of action of the positive modulator PNU-120596 on α7 nicotinic acetylcholine receptors

Szabo, A. K., Pesti, K., Mike, Á., & Vizi, E. S. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.033 · Cited by 22 · see citing works

PF-06827443 Displays Robust Allosteric Agonist and Positive Allosteric Modulator Activity in High Receptor Reserve and Native Systems

Moran, S. P., Cho, H. P., Maksymetz, J., et al. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00106 · Cited by 29 · see citing works

Use of N-ethylmaleimide to directly determine the proportion of β-adrenergic receptors exhibiting high affinity for agonists on human mononuclear leukocyte membranes

Rigby, J. W., & Wood, A. J. J. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90428-0 · Cited by 1 · see citing works

R-(−)-β-phenyl-GABA is a full agonist at GABAB receptors in brain slices but a partial agonist in the ileum

Ong, J. A., Kerr, D. I. B., Doolette, D. J., et al. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90364-n · Cited by 27 · see citing works